We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.99%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$63.9B
AUM Growth
+$3.43B
(+5.7%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
4,866
New
886
Increased
1,406
Reduced
1,667
Closed
823
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3B |
| 2 |
Microsoft
MSFT
|
+$508M |
| 3 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$209M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$190M |
| 5 |
Qualcomm
QCOM
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 3 |
Oracle
ORCL
|
+$168M |
| 4 |
Gilead Sciences
GILD
|
+$140M |
| 5 |
Snowflake
SNOW
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.98% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Financials | 4.35% |
| 4 | Healthcare | 4.2% |
| 5 | Industrials | 3.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
BlackRock TCP Capital
TCPC
$265M
| $93.8K | ﹤0.01% |
+11,311
| New | +$109K |
|
3877
Real Brokerage
REAX
$368M
| $93.4K | ﹤0.01% |
+16,834
| New | +$95.7K |
|
|
ETNB
3878
DELISTED
89bio
ETNB
| $93.4K | ﹤0.01% |
12,617
-28,245
| -69% | -$237K |
|
|
LAZR
3879
PUT
DELISTED
Luminar Technologies
LAZR
| $92.1K | ﹤0.01% |
+6,827
| New | +$124K |
|
3880
Personalis
PSNL
$1.26B
| $91.6K | ﹤0.01% |
+17,020
| New | +$70.1K |
|
3881
CS Disco
LAW
$226M
| $90.7K | ﹤0.01% |
+15,429
| New | +$86.1K |
|
3882
Solid Power
SLDP
$468M
| $90.7K | ﹤0.01% |
67,184
+27,201
| +68% | +$43K |
|
3883
ASP Isotopes
ASPI
$487M
| $90.7K | ﹤0.01% |
+32,615
| New | +$86.7K |
|
3884
Bioceres Crop Solutions
BIOX
$21.9M
| $90K | ﹤0.01% |
+11,440
| New | +$115K |
|
3885
Fortuna Silver Mines
FSM
$2.59B
| $89.4K | ﹤0.01% |
+19,304
| New | +$91.5K |
|
3886
SIGA Technologies
SIGA
$223M
| $89.2K | ﹤0.01% |
+13,220
| New | +$115K |
|
3887
PUT
Lucid Motors
LCID
$2.46B
| $88.3K | ﹤0.01% |
2,500
| – | – |
|
|
AILE
3888
DELISTED
iLearningEngines, Inc. Common Stock
AILE
| $88.1K | ﹤0.01% |
52,725
+39,127
| +288% | +$200K |
|
|
CMPS
3889
Compass Pathways
CMPS
$1.52B
| $88K | ﹤0.01% |
+13,966
| New | +$98.5K |
|
3890
Kodiak Sciences
KOD
$2.59B
| $87.4K | ﹤0.01% |
33,468
-20,520
| -38% | -$54.5K |
|
|
AGEN
3891
Agenus
AGEN
$249M
| $87.3K | ﹤0.01% |
15,938
-20,713
| -57% | -$155K |
|
3892
IHS Holding
IHS
$2.77B
| $87.1K | ﹤0.01% |
29,134
+13,793
| +90% | +$42.4K |
|
3893
Solid Biosciences
SLDB
$771M
| $86.9K | ﹤0.01% |
12,463
-4,926
| -28% | -$40K |
|
3894
Altisource Portfolio Solutions
ASPS
$65.4M
| $86.2K | ﹤0.01% |
8,978
+2,583
| +40% | +$25.2K |
|
|
MREO
3895
Mereo BioPharma
MREO
$45.9M
| $85.6K | ﹤0.01% |
20,825
-6,472
| -24% | -$26.8K |
|
3896
Zevra Therapeutics
ZVRA
$563M
| $84.3K | ﹤0.01% |
+12,150
| New | +$82.5K |
|
3897
Identive
INVE
$64.6M
| $84.3K | ﹤0.01% |
23,881
+7,547
| +46% | +$27.6K |
|
3898
CALL
Wrap Technologies
WRAP
$94.8M
| $83.7K | ﹤0.01% |
55,800
| – | – |
|
|
JMIA
3899
Jumia Technologies
JMIA
$726M
| $83.1K | ﹤0.01% |
15,555
| – | – |
|
3900
VistaGen Therapeutics
VTGN
$9.29M
| $83K | ﹤0.01% |
27,575
+16,180
| +142% | +$55.2K |
|
Similar funds
Squarepoint's Q3 2024 Portfolio in Review
As of Q3 2024, Squarepoint held 4,866 positions worth $63.9B, up 5.7% from $60.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Squarepoint's Q3 2024 filing shows 886 new, 1,406 increased, 1,667 reduced and 823 closed positions. Its largest new stake was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $711M.
By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 9.1% a quarter earlier, followed by Consumer Discretionary and Financials.
- Squarepoint's largest Q3 2024 buy was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $3B increase.
- Squarepoint's biggest Q3 2024 reduction was Bristol-Myers Squibb, cutting an estimated $184M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q3 2024, selling an estimated $711M.
- Squarepoint's ten largest holdings make up 21% of its $63.9B portfolio in Q3 2024.
- Squarepoint opened 886 new positions and closed 823 in Q3 2024.
- Squarepoint's portfolio value rose 5.7% quarter-over-quarter to $63.9B.
Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.